158.50
-4.00
(-2.46%)
At close: 1:30:18 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,446,819.00
2,397,675.00
2,777,524.00
1,964,499.00
1,526,389.00
Cost of Revenue
2,125,139.00
1,540,519.00
1,544,792.00
1,125,164.00
976,201.00
Gross Profit
1,321,680.00
857,156.00
1,232,732.00
839,335.00
550,188.00
Operating Expense
620,895.00
522,449.00
519,281.00
432,839.00
388,471.00
Operating Income
700,785.00
334,707.00
713,451.00
406,496.00
161,717.00
Net Non Operating Interest Income Expense
-22,295.00
-20,327.00
-30,859.00
-21,212.00
-13,141.00
Pretax Income
659,130.00
296,081.00
712,789.00
404,289.00
115,738.00
Tax Provision
40,338.00
1,519.00
98,780.00
-39,343.00
-12,334.00
Net Income Common Stockholders
618,707.00
301,613.00
617,431.00
443,632.00
128,072.00
Diluted NI Available to Com Stockholders
618,707.00
301,613.00
617,431.00
443,632.00
128,072.00
Basic EPS
9.82
4.79
11.11
8.11
2.35
Diluted EPS
9.79
4.78
11.07
8.08
2.31
Basic Average Shares
63,061.71
63,000.00
55,588.00
54,727.00
54,519.00
Diluted Average Shares
63,222.27
63,138.00
55,790.00
54,874.00
55,345.00
Total Expenses
2,746,034.00
2,062,968.00
2,064,073.00
1,558,003.00
1,364,672.00
Net Income from Continuing & Discontinued Operation
618,707.00
301,613.00
617,431.00
443,632.00
128,072.00
Normalized Income
608,076.95
304,210.60
620,471.80
443,632.00
128,072.00
Interest Income
7,569.00
12,521.00
1,274.00
260.00
342.00
Interest Expense
29,864.00
32,848.00
32,133.00
21,472.00
13,483.00
Net Interest Income
-22,295.00
-20,327.00
-30,859.00
-21,212.00
-13,141.00
EBIT
688,994.00
328,929.00
744,922.00
425,761.00
129,221.00
EBITDA
1,112,219.00
733,587.00
1,080,953.00
667,512.00
306,916.00
Reconciled Cost of Revenue
2,125,139.00
1,540,519.00
1,544,792.00
1,125,164.00
976,201.00
Reconciled Depreciation
423,225.00
404,658.00
336,031.00
241,751.00
177,695.00
Net Income from Continuing Operation Net Minority Interest
618,707.00
301,613.00
617,431.00
443,632.00
128,072.00
Total Unusual Items Excluding Goodwill
11,323.00
-2,611.00
-3,530.00
--
--
Total Unusual Items
11,323.00
-2,611.00
-3,530.00
--
--
Normalized EBITDA
1,100,896.00
736,198.00
1,084,483.00
667,512.00
306,916.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
692.95
-13.40
-489.20
--
--
12/31/2020 - 8/14/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4771.TW Vizionfocus Inc.
161.00
-0.62%
6491.TW Pegavision Corporation
357.00
+0.14%
1565.TWO St.Shine Optical Co.,Ltd.
188.00
-1.57%
1786.TW SciVision Biotech Inc.
111.50
-1.76%
6612.TWO ICARES Medicus, Inc.
117.50
-2.08%
1783.TW Maxigen Biotech Inc.
49.30
-5.37%
1752.TW Nang Kuang Pharmaceutical Co., Ltd.
41.35
-0.24%
5312.TWO Formosa Optical Technology Co.,Ltd.
107.00
-0.93%
4737.TW Bionime Corporation
58.50
-2.17%
4107.TWO Bioteque Corporation
121.50
0.00%